Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{91c32215197b476e96199efbadf5904a,
title = "A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer",
abstract = "Previous reports have shown that the proteomic markers apolipoprotein A1, hepcidin, transferrin, inter-alpha trypsin IV internal fragment, transthyretin, connective-tissue activating protein 3 and beta-2 microglobulin may discriminate between a benign pelvic mass and ovarian cancer (OC). The aim was to determine if these serum proteomic biomarkers alone as well as in combination with age and serum CA125, could be helpful in triage of women with a pelvic mass.",
keywords = "Adult, Aged, Aged, 80 and over, CA-125 Antigen, Female, Humans, Logistic Models, Middle Aged, Neoplasm Proteins, Odds Ratio, Ovarian Neoplasms, Proteomics, Sensitivity and Specificity, Tumor Markers, Biological",
author = "Claus H{\o}gdall and Fung, {Eric T} and Christensen, {Ib J} and Lotte Nedergaard and Engelholm, {Svend A} and Petri, {Anette L} and Signe Risum and Lene Lundvall and Christine Yip and Pedersen, {Anette T} and Dorthe Hartwell and Lee Lomas and H{\o}gdall, {Estrid V S}",
note = "Copyright {\circledC} 2011 Elsevier Inc. All rights reserved.",
year = "2011",
doi = "10.1016/j.ygyno.2011.07.018",
language = "English",
volume = "123",
pages = "308--13",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press",
number = "2",

}

RIS

TY - JOUR

T1 - A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

AU - Høgdall, Claus

AU - Fung, Eric T

AU - Christensen, Ib J

AU - Nedergaard, Lotte

AU - Engelholm, Svend A

AU - Petri, Anette L

AU - Risum, Signe

AU - Lundvall, Lene

AU - Yip, Christine

AU - Pedersen, Anette T

AU - Hartwell, Dorthe

AU - Lomas, Lee

AU - Høgdall, Estrid V S

N1 - Copyright © 2011 Elsevier Inc. All rights reserved.

PY - 2011

Y1 - 2011

N2 - Previous reports have shown that the proteomic markers apolipoprotein A1, hepcidin, transferrin, inter-alpha trypsin IV internal fragment, transthyretin, connective-tissue activating protein 3 and beta-2 microglobulin may discriminate between a benign pelvic mass and ovarian cancer (OC). The aim was to determine if these serum proteomic biomarkers alone as well as in combination with age and serum CA125, could be helpful in triage of women with a pelvic mass.

AB - Previous reports have shown that the proteomic markers apolipoprotein A1, hepcidin, transferrin, inter-alpha trypsin IV internal fragment, transthyretin, connective-tissue activating protein 3 and beta-2 microglobulin may discriminate between a benign pelvic mass and ovarian cancer (OC). The aim was to determine if these serum proteomic biomarkers alone as well as in combination with age and serum CA125, could be helpful in triage of women with a pelvic mass.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - CA-125 Antigen

KW - Female

KW - Humans

KW - Logistic Models

KW - Middle Aged

KW - Neoplasm Proteins

KW - Odds Ratio

KW - Ovarian Neoplasms

KW - Proteomics

KW - Sensitivity and Specificity

KW - Tumor Markers, Biological

U2 - 10.1016/j.ygyno.2011.07.018

DO - 10.1016/j.ygyno.2011.07.018

M3 - Journal article

VL - 123

SP - 308

EP - 313

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -

ID: 33230114